AbbVie Inc.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference a743b8b78b
Drug names41First applicant · distinct drug namesAcceptance records228First applicant · distinct acceptance numbersUnder-review numbers36First applicant · current under-review listCo-applicant records14Subsequent applicant only · separate count
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/11 06:42.
Drug filings
228 acceptance records as first applicant, grouped into 41 source drug names. Source data as of 2026/11/11 06:42.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
No verified English name 5 records · Latest accepted 2026/10/28
Import · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2600289 | Import | 2026/10/28 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2600126 | Import | 2026/06/04 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2500213 | Import | 2025/11/08 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2400179 | Import | 2024/09/25 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2400132 | Import | 2024/07/25 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/10/26
Import · 2
No verified English name 1 records · Latest accepted 2026/10/23
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2600282 | Import | 2026/10/23 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/10/21
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2600278 | Import | 2026/10/21 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 21 records · Latest accepted 2026/10/21
Supplement · 9Import · 9Import re-registration · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHB2600568 | Supplement | 2026/10/21 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JYHB2600567 | Supplement | 2026/10/21 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JYHB2600566 | Supplement | 2026/10/21 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHS2600096 | Import | 2026/08/20 | AbbVie Inc.; AbbVie Ireland NL B.V.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXHS2600095 | Import | 2026/08/20 | AbbVie Inc.; AbbVie Ireland NL B.V.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXHS2600094 | Import | 2026/08/20 | AbbVie Inc.; AbbVie Ireland NL B.V.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JYHZ2500008 | Import re-registration | 2025/01/16 | AbbVie Inc.; AbbVie Ireland NL B.V.; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd | CDE ↗ |
| JYHZ2500007 | Import re-registration | 2025/01/16 | AbbVie Inc.; AbbVie Ireland NL B.V.; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd | CDE ↗ |
| JYHZ2500006 | Import re-registration | 2025/01/16 | AbbVie Inc.; AbbVie Ireland NL B.V.; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd | CDE ↗ |
| JXHS2400072 | Import | 2024/09/20 | AbbVie Inc.; AbbVie Ireland NL B.V; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
| JXHS2400071 | Import | 2024/09/20 | AbbVie Inc.; AbbVie Ireland NL B.V; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
| JXHS2400070 | Import | 2024/09/20 | AbbVie Inc.; AbbVie Ireland NL B.V; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
| JXHS2300053 | Import | 2023/06/21 | AbbVie Inc.; AbbVie Ireland NL B.V; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
| JXHS2300052 | Import | 2023/06/21 | AbbVie Inc.; AbbVie Ireland NL B.V; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
| JXHS2300051 | Import | 2023/06/21 | AbbVie Inc.; AbbVie Ireland NL B.V; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
| JYHB2300037 | Supplement | 2023/01/11 | AbbVie Inc.; AbbVie Ireland NL B.V | CDE ↗ |
| JYHB2300036 | Supplement | 2023/01/11 | AbbVie Inc.; AbbVie Ireland NL B.V | CDE ↗ |
| JYHB2300035 | Supplement | 2023/01/11 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JYHB2101409 | Supplement | 2021/09/13 | AbbVie Inc.; AbbVie Ireland NL B.V | CDE ↗ |
| JYHB2101408 | Supplement | 2021/09/13 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JYHB2101407 | Supplement | 2021/09/13 | AbbVie Inc.; AbbVie Ireland NL B.V | CDE ↗ |
No verified English name 8 records · Latest accepted 2026/10/15
Supplement · 5Import · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSB2600194 | Supplement | 2026/10/15 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JXSB2500044 | Supplement | 2025/05/22 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JXSL2400226 | Import | 2024/11/23 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSB2300027 | Supplement | 2023/03/11 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JXSB2200129 | Supplement | 2022/10/15 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JXSL2200173 | Import | 2022/09/29 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai)Co. Ltd | CDE ↗ |
| JXSB2200118 | Supplement | 2022/09/16 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JXSL2200002 | Import | 2022/01/05 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai)Co. Ltd | CDE ↗ |
No verified English name 19 records · Latest accepted 2026/10/13
Supplement · 6Import · 13
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSB2600191 | Supplement | 2026/10/13 | AbbVie Inc.; Patheon Italia S.p.A.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXSB2600190 | Supplement | 2026/10/13 | AbbVie Inc.; AbbVie Biotechnology Ltd.; AbbVie Deutschland GmbH & Co. KG | CDE ↗ |
| JXSB2600189 | Supplement | 2026/10/13 | AbbVie Inc.; AbbVie Biotechnology Ltd. | CDE ↗ |
| JXSB2600188 | Supplement | 2026/10/13 | AbbVie Inc.; AbbVie Biotechnology Ltd. | CDE ↗ |
| JXSB2600187 | Supplement | 2026/10/13 | AbbVie Inc.; Patheon Italia S.p.A.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXSL2600185 | Import | 2026/08/03 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2600184 | Import | 2026/08/03 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2500131 | Import | 2025/07/25 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2500130 | Import | 2025/07/25 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2500129 | Import | 2025/07/25 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2500128 | Import | 2025/07/25 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2500127 | Import | 2025/07/25 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSB2500069 | Supplement | 2025/07/22 | AbbVie Inc.; AbbVie Deutschland GmbH & Co. KG; AbbVie Biotechnology Ltd. | CDE ↗ |
| JXSL2400040 | Import | 2024/02/06 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2400039 | Import | 2024/02/06 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2400038 | Import | 2024/02/06 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2400037 | Import | 2024/02/06 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2400036 | Import | 2024/02/06 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2400009 | Import | 2024/01/10 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 16 records · Latest accepted 2026/09/23
Import · 14Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2600258 | Import | 2026/09/23 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| JXSL2600257 | Import | 2026/09/23 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| JXSL2600229 | Import | 2026/08/26 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| JXSL2600222 | Import | 2026/08/24 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| JXSB2600152 | Supplement | 2026/08/20 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JXSB2600151 | Supplement | 2026/08/20 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JXSL2600181 | Import | 2026/08/03 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2600180 | Import | 2026/08/03 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2600155 | Import | 2026/07/08 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| JXSL2600154 | Import | 2026/07/08 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| JXSL2600118 | Import | 2026/05/21 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2600078 | Import | 2026/03/13 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2600077 | Import | 2026/03/13 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2600045 | Import | 2026/02/11 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2600044 | Import | 2026/02/11 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2500200 | Import | 2025/10/15 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 5 records · Latest accepted 2026/09/11
Import · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2600401 | Import | 2026/09/11 | AbbVie Inc.; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
| JXHS2600103 | Import | 2026/08/25 | AbbVie Inc. | CDE ↗ |
| JXHS2600102 | Import | 2026/08/25 | AbbVie Inc. | CDE ↗ |
| JXHL2600293 | Import | 2026/07/28 | AbbVie Inc.; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
| JXHL2600292 | Import | 2026/07/28 | AbbVie Inc.; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
Upadacitinib Sustained-release Tablets 8 records · Latest accepted 2026/09/11
Import · 4Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2600400 | Import | 2026/09/11 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXHL2600308 | Import | 2026/07/30 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXHL2600298 | Import | 2026/07/28 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXHL2600297 | Import | 2026/07/28 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXHB2600030 | Supplement | 2026/03/06 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2600029 | Supplement | 2026/03/06 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2600028 | Supplement | 2026/03/06 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2600027 | Supplement | 2026/03/06 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
No verified English name 8 records · Latest accepted 2026/09/02
Import · 8
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2600391 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| JXHL2600390 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| JXHL2600389 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| JXHL2600388 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| JXHL2600387 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| JXHL2600386 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| JXHL2600385 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| JXHL2600384 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/08/03
Import · 2
No verified English name 1 records · Latest accepted 2026/07/30
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2600178 | Import | 2026/07/30 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2026/07/30
Import · 2
No verified English name 4 records · Latest accepted 2026/07/16
Supplement · 3Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSB2600114 | Supplement | 2026/07/16 | AbbVie Inc.; AbbVie Ireland NL B.V.; AbbVie Deutschland GmbH & Co. KG | CDE ↗ |
| JXSB2400173 | Supplement | 2024/12/21 | AbbVie Inc.; AbbVie Ireland NL B.V.; AbbVie Deutschland GmbH & Co. KG | CDE ↗ |
| JXSB2400123 | Supplement | 2024/09/19 | AbbVie Inc.; AbbVie Ireland NL B.V.; AbbVie Deutschland GmbH & Co. KG | CDE ↗ |
| JXSL2400007 | Import | 2024/01/06 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 7 records · Latest accepted 2026/06/18
Supplement · 4Import · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2600166 | Supplement | 2026/06/18 | AbbVie Inc.; AbbVie Biotechnology Ltd. | CDE ↗ |
| JYSB2600165 | Supplement | 2026/06/18 | AbbVie Inc.; AbbVie Biotechnology Ltd. | CDE ↗ |
| JYSB2600092 | Supplement | 2026/04/11 | AbbVie Inc.; Patheon Italia S.p.A. | CDE ↗ |
| JYSB2600091 | Supplement | 2026/04/11 | AbbVie Inc.; Patheon Italia S.p.A. | CDE ↗ |
| JXSS2400046 | Import | 2024/06/04 | AbbVie Inc.; Patheon Italia S.p.A.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSS2400045 | Import | 2024/06/04 | AbbVie Inc.; Patheon Italia S.p.A.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSS2300051 | Import | 2023/07/06 | AbbVie Inc.; Patheon Italia S.p.A.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 34 records · Latest accepted 2026/06/08
Supplement · 15Import · 19
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHB2600070 | Supplement | 2026/06/08 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2600069 | Supplement | 2026/06/08 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2600068 | Supplement | 2026/06/08 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2600067 | Supplement | 2026/06/08 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2600051 | Supplement | 2026/04/01 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2500034 | Supplement | 2025/04/03 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2500033 | Supplement | 2025/04/03 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2400136 | Supplement | 2024/08/09 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2400135 | Supplement | 2024/08/09 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHL2400129 | Import | 2024/06/07 | AbbVie Inc. | CDE ↗ |
| JXHL2400128 | Import | 2024/06/07 | AbbVie Inc. | CDE ↗ |
| JXHL2400127 | Import | 2024/06/07 | AbbVie Inc. | CDE ↗ |
| JXHL2400112 | Import | 2024/05/13 | AbbVie Inc. | CDE ↗ |
| JXHL2400111 | Import | 2024/05/13 | AbbVie Inc. | CDE ↗ |
| JXHL2400110 | Import | 2024/05/13 | AbbVie Inc. | CDE ↗ |
| JXHB2300168 | Supplement | 2023/11/01 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2300167 | Supplement | 2023/11/01 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHL2300251 | Import | 2023/10/12 | AbbVie Inc. | CDE ↗ |
| JXHB2300133 | Supplement | 2023/08/23 | AbbVie Inc.; Abbvie Ireland NL.B.V. | CDE ↗ |
| JXHB2300132 | Supplement | 2023/08/23 | AbbVie Inc.; Abbvie Ireland NL.B.V. | CDE ↗ |
| JXHL2300158 | Import | 2023/07/04 | AbbVie Inc. | CDE ↗ |
| JXHL2300157 | Import | 2023/07/04 | AbbVie Inc. | CDE ↗ |
| JXHL2300134 | Import | 2023/06/01 | AbbVie Inc. | CDE ↗ |
| JXHL2300133 | Import | 2023/05/30 | AbbVie Inc. | CDE ↗ |
| JXHL2300132 | Import | 2023/05/30 | AbbVie Inc. | CDE ↗ |
| JXHL2300056 | Import | 2023/03/23 | AbbVie Inc. | CDE ↗ |
| JXHL2300055 | Import | 2023/03/23 | AbbVie Inc. | CDE ↗ |
| JXHL2300034 | Import | 2023/02/24 | AbbVie Inc. | CDE ↗ |
| JXHL2200312 | Import | 2022/10/27 | AbbVie Inc. | CDE ↗ |
| JXHL2200311 | Import | 2022/10/27 | AbbVie Inc. | CDE ↗ |
| JXHL2200247 | Import | 2022/08/18 | AbbVie Inc. | CDE ↗ |
| JXHL2200169 | Import | 2022/07/04 | AbbVie Inc. | CDE ↗ |
| JXHB2101121 | Supplement | 2021/12/28 | AbbVie Inc. | CDE ↗ |
| JXHB2101022 | Supplement | 2021/06/04 | AbbVie Inc. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/06/01
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2600125 | Import | 2026/06/01 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/04/28
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2600106 | Import | 2026/04/28 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 7 records · Latest accepted 2026/02/15
Supplement · 2Import · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHB2600021 | Supplement | 2026/02/15 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2600020 | Supplement | 2026/02/15 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHL2400131 | Import | 2024/06/08 | AbbVie Inc.; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
| JXHL2400130 | Import | 2024/06/08 | AbbVie Inc.; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
| JXHL2400097 | Import | 2024/05/07 | AbbVie Inc.; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
| JXHL2400096 | Import | 2024/05/07 | AbbVie Inc.; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
| JXHL2300042 | Import | 2023/03/04 | AbbVie Inc. | CDE ↗ |
No verified English name 1 records · Latest accepted 2026/01/20
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2600020 | Import | 2026/01/20 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2025/12/16
Supplement · 1Import · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2500287 | Supplement | 2025/12/16 | AbbVie Inc.; Patheon Italia S.p.A.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXSS2400047 | Import | 2024/06/04 | AbbVie Inc.; Patheon Italia S.p.A.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSS2300052 | Import | 2023/07/06 | AbbVie Inc.; Patheon Italia S.p.A.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 6 records · Latest accepted 2025/12/04
Supplement · 1Import · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSB2500146 | Supplement | 2025/12/04 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JXSL2500137 | Import | 2025/08/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2500002 | Import | 2025/01/03 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2400194 | Import | 2024/10/17 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2400191 | Import | 2024/10/11 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2400060 | Import | 2024/03/16 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 4 records · Latest accepted 2025/10/31
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYSB2500257 | Supplement | 2025/10/31 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JYSB2500245 | Supplement | 2025/10/17 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JYSB2500057 | Supplement | 2025/03/11 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| JYSB2400263 | Supplement | 2024/12/18 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
No verified English name 10 records · Latest accepted 2025/09/03
Supplement · 4Import · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSB2500110 | Supplement | 2025/09/03 | AbbVie Inc.; Vetter Pharma-Fertigung GmbH & Co.KG | CDE ↗ |
| JXSB2500042 | Supplement | 2025/05/20 | AbbVie Inc.; Vetter Pharma-Fertigung GmbH & Co.KG | CDE ↗ |
| JXSB2400178 | Supplement | 2024/12/26 | AbbVie Inc.; Vetter Pharma-Fertigung GmbH & Co.KG | CDE ↗ |
| JXSL2400100 | Import | 2024/05/24 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2400099 | Import | 2024/05/24 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JYSB2300102 | Supplement | 2023/06/03 | AbbVie Inc.; Vetter Pharma-Fertigung GmbH & Co.KG | CDE ↗ |
| JXSL2300100 | Import | 2023/06/01 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2300003 | Import | 2023/01/04 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2200148 | Import | 2022/08/30 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2101074 | Import | 2021/07/27 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 10 records · Latest accepted 2025/09/03
Supplement · 4Import · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSB2500111 | Supplement | 2025/09/03 | AbbVie Inc.; Vetter Pharma-Fertigung GmbH & Co.KG | CDE ↗ |
| JXSB2500043 | Supplement | 2025/05/20 | AbbVie Inc.; Vetter Pharma-Fertigung GmbH & Co.KG | CDE ↗ |
| JXSB2400176 | Supplement | 2024/12/26 | AbbVie Inc.; Vetter Pharma-Fertigung GmbH & Co.KG | CDE ↗ |
| JXSL2400102 | Import | 2024/05/24 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2400101 | Import | 2024/05/24 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSB2300068 | Supplement | 2023/06/03 | AbbVie Inc.; Vetter Pharma-Fertigung GmbH & Co.KG | CDE ↗ |
| JXSL2300079 | Import | 2023/04/25 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2300002 | Import | 2023/01/04 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2200149 | Import | 2022/08/30 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXSL2101075 | Import | 2021/07/27 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/05/09
Import · 2
No verified English name 1 records · Latest accepted 2025/04/09
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2500055 | Import | 2025/04/09 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 3 records · Latest accepted 2025/02/20
Import · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHL2500029 | Import | 2025/02/20 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXHL2500028 | Import | 2025/02/20 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| JXHL2500027 | Import | 2025/02/20 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 2 records · Latest accepted 2025/01/03
Import · 2
No verified English name 2 records · Latest accepted 2024/09/04
Import · 2
Brimonidine Tartrate Eye Drops 4 records · Latest accepted 2024/06/15
Import re-registration · 2Supplement · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JYHZ2400157 | Import re-registration | 2024/06/15 | AbbVie Inc.; Allergan Sales LLC; Allergan Information Consulting (Shanghai) Co. Ltd. | CDE ↗ |
| JYHZ2400156 | Import re-registration | 2024/06/15 | AbbVie Inc.; Allergan Sales LLC; Allergan Information Consulting (Shanghai) Co. Ltd. | CDE ↗ |
| JYHB2400007 | Supplement | 2024/01/05 | AbbVie Inc.; Allergan Sales LLC | CDE ↗ |
| JYHB2400006 | Supplement | 2024/01/05 | AbbVie Inc.; Allergan Sales LLC | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/03/23
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2400061 | Import | 2024/03/23 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 9 records · Latest accepted 2024/03/09
Supplement · 9
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSB2400026 | Supplement | 2024/03/09 | AbbVie Inc.; Boehringer Ingelheim Pharma GmbH & Co KG; AbbVie Biotechnology LTD | CDE ↗ |
| JXSB2300061 | Supplement | 2023/05/16 | AbbVie Inc.; Boehringer Ingelheim Pharma GmbH & Co KG | CDE ↗ |
| JXSB2300060 | Supplement | 2023/05/16 | AbbVie Inc.; Boehringer Ingelheim Pharma GmbH & Co KG | CDE ↗ |
| JXSB2300059 | Supplement | 2023/05/16 | AbbVie Inc.; Patheon Italia S.P.A | CDE ↗ |
| JXSB2300058 | Supplement | 2023/05/16 | AbbVie Inc.; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSB2300057 | Supplement | 2023/05/16 | AbbVie Inc.; Boehringer Ingelheim Pharma GmbH & Co KG | CDE ↗ |
| JXSB2300056 | Supplement | 2023/05/16 | AbbVie Inc.; Patheon Italia S.P.A | CDE ↗ |
| JXSB2101108 | Supplement | 2021/12/10 | AbbVie Inc.; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
| JXSB2101107 | Supplement | 2021/12/10 | AbbVie Inc.; Boehringer Ingelheim Pharma GmbH & Co. KG | CDE ↗ |
No verified English name 1 records · Latest accepted 2024/02/05
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2400035 | Import | 2024/02/05 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
No verified English name 1 records · Latest accepted 2023/09/07
Import · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXSL2300164 | Import | 2023/09/07 | AbbVie Inc.; Allergan Information Consulting (Shanghai) Co. Ltd | CDE ↗ |
No verified English name 6 records · Latest accepted 2023/06/03
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHB2300091 | Supplement | 2023/06/03 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2300090 | Supplement | 2023/06/03 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2300089 | Supplement | 2023/06/03 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2200152 | Supplement | 2022/09/23 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2200151 | Supplement | 2022/09/23 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2200150 | Supplement | 2022/09/23 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
No verified English name 3 records · Latest accepted 2022/10/14
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| JXHB2200161 | Supplement | 2022/10/14 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2200160 | Supplement | 2022/10/14 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| JXHB2200159 | Supplement | 2022/10/14 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
No verified English name 2 records · Latest accepted 2021/04/27
Supplement · 2
No verified English name 2 records · Latest accepted 2021/02/03
Import · 2
No verified English name 2 records · Latest accepted 2021/02/03
Import · 2
Changes in the last 90 days
39 events from 2026/08/14 to 2026/11/11. CDE data as of 2026/11/11 06:42; NMPA data as of 2026/11/10 18:31.
This source was last successfully updated at 2026/11/10 18:31; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Accepted: 35 applicationsNo longer listed under review: 4 applications
- 2026/11/05No longer listed under review
No verified English name
JXSL2600229
Fact date: 2026/11/05 · Site observation date: 2026/11/05
Accepted: 2026/08/26
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/11/04No longer listed under review
No verified English name
JXSL2600222
Fact date: 2026/11/04 · Site observation date: 2026/11/04
Accepted: 2026/08/24
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/10/28Accepted
No verified English name
JXSL2600289
Fact date: 2026/10/28 · Site observation date: 2026/10/29
View source ↗ - 2026/10/27No longer listed under review
No verified English name
JXSB2600152
Fact date: 2026/10/27 · Site observation date: 2026/10/27
Accepted: 2026/08/20
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/10/27No longer listed under review
No verified English name
JXSB2600151
Fact date: 2026/10/27 · Site observation date: 2026/10/27
Accepted: 2026/08/20
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ - 2026/10/26Accepted
No verified English name
JXSL2600285
Fact date: 2026/10/26 · Site observation date: 2026/10/27
View source ↗ - 2026/10/23Accepted
No verified English name
JXSL2600282
Fact date: 2026/10/23 · Site observation date: 2026/10/24
View source ↗ - 2026/10/21Accepted
No verified English name
JYHB2600568
Fact date: 2026/10/21 · Site observation date: 2026/10/22
View source ↗ - 2026/10/21Accepted
No verified English name
JYHB2600567
Fact date: 2026/10/21 · Site observation date: 2026/10/22
View source ↗ - 2026/10/21Accepted
No verified English name
JYHB2600566
Fact date: 2026/10/21 · Site observation date: 2026/10/22
View source ↗ - 2026/10/21Accepted
No verified English name
JXSL2600278
Fact date: 2026/10/21 · Site observation date: 2026/10/22
View source ↗ - 2026/10/15Accepted
No verified English name
JXSB2600194
Fact date: 2026/10/15 · Site observation date: 2026/10/22
View source ↗ - 2026/10/13Accepted
No verified English name
JXSB2600191
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ - 2026/10/13Accepted
No verified English name
JXSB2600190
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ - 2026/10/13Accepted
No verified English name
JXSB2600189
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ - 2026/10/13Accepted
No verified English name
JXSB2600188
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ - 2026/10/13Accepted
No verified English name
JXSB2600187
Fact date: 2026/10/13 · Site observation date: 2026/10/22
View source ↗ - 2026/09/23Accepted
No verified English name
JXSL2600258
Fact date: 2026/09/23 · Site observation date: 2026/10/22
View source ↗ - 2026/09/23Accepted
No verified English name
JXSL2600257
Fact date: 2026/09/23 · Site observation date: 2026/10/22
View source ↗ - 2026/09/11Accepted
No verified English name
JXHL2600401
Fact date: 2026/09/11 · Site observation date: 2026/10/22
View source ↗ - 2026/09/11Accepted
Upadacitinib Sustained-release Tablets
JXHL2600400
Fact date: 2026/09/11 · Site observation date: 2026/10/22
View source ↗ - 2026/09/02Accepted
No verified English name
JXHL2600391
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗ - 2026/09/02Accepted
No verified English name
JXHL2600390
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗ - 2026/09/02Accepted
No verified English name
JXHL2600389
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗ - 2026/09/02Accepted
No verified English name
JXHL2600388
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗ - 2026/09/02Accepted
No verified English name
JXHL2600387
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗ - 2026/09/02Accepted
No verified English name
JXHL2600386
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗ - 2026/09/02Accepted
No verified English name
JXHL2600385
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗ - 2026/09/02Accepted
No verified English name
JXHL2600384
Fact date: 2026/09/02 · Site observation date: 2026/10/22
View source ↗ - 2026/08/28Accepted
No verified English name
JXSL2600232
Fact date: 2026/08/28 · Site observation date: 2026/10/22
View source ↗ - 2026/08/26Accepted
No verified English name
JXSL2600229
Fact date: 2026/08/26 · Site observation date: 2026/10/22
View source ↗ - 2026/08/25Accepted
No verified English name
JXHS2600103
Fact date: 2026/08/25 · Site observation date: 2026/10/22
View source ↗ - 2026/08/25Accepted
No verified English name
JXHS2600102
Fact date: 2026/08/25 · Site observation date: 2026/10/22
View source ↗ - 2026/08/24Accepted
No verified English name
JXSL2600222
Fact date: 2026/08/24 · Site observation date: 2026/10/22
View source ↗ - 2026/08/20Accepted
No verified English name
JXSB2600152
Fact date: 2026/08/20 · Site observation date: 2026/10/22
View source ↗ - 2026/08/20Accepted
No verified English name
JXSB2600151
Fact date: 2026/08/20 · Site observation date: 2026/10/22
View source ↗ - 2026/08/20Accepted
No verified English name
JXHS2600096
Fact date: 2026/08/20 · Site observation date: 2026/10/22
View source ↗ - 2026/08/20Accepted
No verified English name
JXHS2600095
Fact date: 2026/08/20 · Site observation date: 2026/10/22
View source ↗ - 2026/08/20Accepted
No verified English name
JXHS2600094
Fact date: 2026/08/20 · Site observation date: 2026/10/22
View source ↗
Under review
36 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | JXSL2600289 | Import | 2026/10/28 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| No verified English name | JXSL2600285 | Import | 2026/10/26 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| No verified English name | JXSL2600282 | Import | 2026/10/23 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| No verified English name | JYHB2600568 | Supplement | 2026/10/21 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| No verified English name | JYHB2600567 | Supplement | 2026/10/21 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| No verified English name | JYHB2600566 | Supplement | 2026/10/21 | AbbVie Inc.; AbbVie Ireland NL B.V. | CDE ↗ |
| No verified English name | JXSL2600278 | Import | 2026/10/21 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| No verified English name | JXSB2600194 | Supplement | 2026/10/15 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
| No verified English name | JXSB2600191 | Supplement | 2026/10/13 | AbbVie Inc.; Patheon Italia S.p.A.; AbbVie Ireland NL B.V. | CDE ↗ |
| No verified English name | JXSB2600190 | Supplement | 2026/10/13 | AbbVie Inc.; AbbVie Biotechnology Ltd.; AbbVie Deutschland GmbH & Co. KG | CDE ↗ |
| No verified English name | JXSB2600189 | Supplement | 2026/10/13 | AbbVie Inc.; AbbVie Biotechnology Ltd. | CDE ↗ |
| No verified English name | JXSB2600188 | Supplement | 2026/10/13 | AbbVie Inc.; AbbVie Biotechnology Ltd. | CDE ↗ |
| No verified English name | JXSB2600187 | Supplement | 2026/10/13 | AbbVie Inc.; Patheon Italia S.p.A.; AbbVie Ireland NL B.V. | CDE ↗ |
| No verified English name | JXSL2600258 | Import | 2026/09/23 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| No verified English name | JXSL2600257 | Import | 2026/09/23 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600401 | Import | 2026/09/11 | AbbVie Inc.; AbbVie Pharmaceutical Trading(Shanghai) Co. Ltd. | CDE ↗ |
| Upadacitinib Sustained-release Tablets | JXHL2600400 | Import | 2026/09/11 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| No verified English name | JXHL2600391 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600390 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600389 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600388 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600387 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600386 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600385 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| No verified English name | JXHL2600384 | Import | 2026/09/02 | AbbVie Inc.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd | CDE ↗ |
| No verified English name | JXHS2600103 | Import | 2026/08/25 | AbbVie Inc. | CDE ↗ |
| No verified English name | JXHS2600102 | Import | 2026/08/25 | AbbVie Inc. | CDE ↗ |
| No verified English name | JXHS2600096 | Import | 2026/08/20 | AbbVie Inc.; AbbVie Ireland NL B.V.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| No verified English name | JXHS2600095 | Import | 2026/08/20 | AbbVie Inc.; AbbVie Ireland NL B.V.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| No verified English name | JXHS2600094 | Import | 2026/08/20 | AbbVie Inc.; AbbVie Ireland NL B.V.; AbbVie Pharmaceutical Trading (Shanghai) Co. Ltd. | CDE ↗ |
| No verified English name | JYSB2600166 | Supplement | 2026/06/18 | AbbVie Inc.; AbbVie Biotechnology Ltd. | CDE ↗ |
| No verified English name | JYSB2600165 | Supplement | 2026/06/18 | AbbVie Inc.; AbbVie Biotechnology Ltd. | CDE ↗ |
| No verified English name | JYSB2600092 | Supplement | 2026/04/11 | AbbVie Inc.; Patheon Italia S.p.A. | CDE ↗ |
| No verified English name | JYSB2600091 | Supplement | 2026/04/11 | AbbVie Inc.; Patheon Italia S.p.A. | CDE ↗ |
| No verified English name | JYSB2500287 | Supplement | 2025/12/16 | AbbVie Inc.; Patheon Italia S.p.A.; AbbVie Ireland NL B.V. | CDE ↗ |
| No verified English name | JYSB2500245 | Supplement | 2025/10/17 | AbbVie Inc.; BSP Pharmaceuticals S.p.A. | CDE ↗ |
Catalogue holder records
3 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/11 06:38. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| No verified English name | AbbVie Inc. | AbbVie Ireland NL B.V. | 国药准字HJ20200054 | 2020/12/02 | Imported originator drug | CDE ↗ |
| No verified English name | AbbVie Inc. | AbbVie Ireland NL B.V. | 国药准字HJ20200053 | 2020/12/02 | Imported originator drug | CDE ↗ |
| No verified English name | AbbVie Inc. | AbbVie Ireland NL B.V. | 国药准字HJ20200055 | 2020/12/02 | Imported originator drug | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
0 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/11 06:40.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| No matching records were found in the currently loaded source data; coverage dates are listed below. | |||||
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
14 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/11 06:42.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| No verified English name | JTS2600161 | Not stated by source | 2026/10/14 | AbbVie Ireland NL B.V.; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2600160 | Not stated by source | 2026/10/14 | AbbVie Ireland NL B.V.; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2600159 | Not stated by source | 2026/10/14 | AbbVie Bioresearch Center; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTH2600120 | Not stated by source | 2026/06/25 | Grand River Aseptic Manufacturing Inc.; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2500068 | Not stated by source | 2025/08/19 | AbbVie Biotechnology Ltd.; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2500067 | Not stated by source | 2025/08/19 | AbbVie Operations Singapore PTE Ltd; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2500066 | Not stated by source | 2025/08/19 | AbbVie Biotechnology Ltd.; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2500065 | Not stated by source | 2025/08/19 | AbbVie Biotechnology Ltd.; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2300062 | Not stated by source | 2023/11/16 | AbbVie Biotechnology Ltd.; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2300061 | Not stated by source | 2023/11/16 | AbbVie Biotechnology Ltd.; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2300048 | Not stated by source | 2023/08/30 | Patheon Italia S.P.A.; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2200102 | Not stated by source | 2022/10/27 | Patheon Italia S.P.A.; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2200101 | Not stated by source | 2022/10/27 | Patheon Italia S.P.A.; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
| No verified English name | JTS2200100 | Not stated by source | 2022/10/27 | Patheon Italia S.P.A.; AbbVie Inc.; Ai Bo Wei Pharmaceuticals Trading (Shanghai) Co., Ltd. romanized | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/11 06:42
- Chemical-drug catalogue
- Last successful update: 2026/11/11 06:38
- Full API register
- Last successful update: 2026/11/11 06:40
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31 · Current coverage may be incomplete
First index-page publication dates: — to —; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only, without new source queries or collection. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Drug names use verified official English names only. Missing names are shown as No verified English name, linking to a Chinese page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized. Original statutory reference numbers are the sole visible Chinese exception.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Chinese free text is not displayed; use the source links or source-name columns in CSV exports.